MAXCYTE, INC.·4

Jun 10, 5:55 PM ET

Masoud Maher 4

4 · MAXCYTE, INC. · Filed Jun 10, 2024

Insider Transaction Report

Form 4
Period: 2024-06-07
Masoud Maher
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2024-06-10$4.90/sh+70,443$345,241100,000 total
  • Purchase

    Common Stock

    2024-06-07$4.87/sh+29,557$143,82429,557 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.84 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.77 to $5.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4-06102024_090649.xmlPrimary